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Image in Focus
Figure 1. Gross view of the mid-ventricular transversal section of the heart showing extensive areas of white fibrosis 
in the endocardium of the left ventricle that has diffusely thickened the lining of the chamber and involved the 
papillary muscles. Note the presence of trabeculae that extend across the myocardium.
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The specimen shown in the picture (Figure 1) 
belonged to a 63-year-old female patient who 
was referred to the Pulmonologist because of a 
long-standing complaint of cough and dyspnea. 
She was a hairdresser and had smoked 8 pack years. 
The work-up, among other examinations, included 
echocardiogram, cinecoronarioangiography, and 
cardiac magnetic resonance imaging (MRI), which 
disclosed the diagnosis of endomyocardial fibrosis. 
She was submitted to surgical treatment with 
partial resection of the left ventricle’s endocardium, 
replacement of the mitral valve by a bioprosthesis, 
and tricuspid valve repair. Four months later, she was 
admitted with fever and signs of sepsis, and died 
soon after. The necropsy and blood culture samples 
(the results of which were available after death) 
revealed endocarditis of the mitral prosthesis due to 
Streptococcus viridans.
Endomyocardial fibrosis (EMF)—also called tropical 
endomyocardial fibrosis—is a restrictive cardiomyopathy 
of unknown cause. It is characterized by the deposition 
of fibrous tissue in the endomyocardium, which leads 
to a restrictive physiology accompanied by a very poor 
prognosis without a specific management. This results 
in demise, which is usually due to heart failure, 
arrhythmias, and thromboembolism. The disease is 
endemic in Africa, where the first case was described 
in 1948 (Uganda),1 but also has a high frequency in 
Asia (India2,3 and China4) and South America (Brazil5 
and Colombia6). Grimaldi et al.7 called it a disease 
of poverty, since it afflicts the rural populations of 
low-income countries. Genetic, environmental, and 
socioeconomic factors may explain the persistent 
particular geographic distribution, as well as the 
decline of prevalence in other areas that have shown 
social and economic improvement. EMF presents a 
bimodal distribution peaking at 10 and 30 years of age. 
Gender seems to lack any predominance, and varies 
according to the series and the country of the study.
The etiopathogenesis of EMF remains in the 
field of hypotheses and far from exact knowledge; 
therefore, it demands systematic research with the 
aid of current technologies. The seemingly implicated 
factors, besides ethnicity, poverty, eosinophilia, 
autoimmunity, and serotonin, are related to: 
(i) the excessive immune response against certain 
parasitic infections; (ii) dietary scarcity (malnutrition); 
(iii) herbal preparations; and (iv) the use of improperly 
processed or cooked cassava as the primary source 
of carbohydrate (because of the ingestion of toxic 
levels of cyanogenic glycoside).8-12 The occurrence of 
familial cases supports the participation of genetic 
predisposition.7 Although not yet a consensus, the 
high prevalence of anti-heart antibodies detected in 
patients with EMF somehow suggests the involvement 
of autoimmunity in the pathogenesis.13 Similarly, the 
usual association of hypereosinophilia with EMF has 
led some authors to consider this entity as the tropical 
variant of hypereosinophilic syndrome, which is found 
in temperate climates with the overproduction of 
interleukin-5 and fibrotic lesions identical to those 
seen in EMF.14
Typically, EMF presents an insidious onset, usually 
associated with fever, pancarditis, and eosinophilia, 
which are morphologically abnormal. This initial 
active form also presents dyspnea, itching, and 
periorbital edema.15 The clinical features of EMF 
will depend on the predominantly affected cardiac 
chamber and the duration of disease. Lower limbs 
edema, ascites, and non-specific gastrointestinal 
complaints (e.g. nausea, vomiting, and anorexia) are 
characteristic of the right ventricular and tricuspid 
valve involvement. However, when the left ventricle 
is affected, dyspnea, exertional dyspnea, orthopnea, 
nocturnal paroxysmal dyspnea, and fatigue will 
predominate. Thromboembolic events, angina-like 
chest pain, arrhythmias, and syncope, may also take 
part of the clinical features of EMF involving the left 
chamber. Growth retardation, testicular atrophy, 
clinical feminization, finger and toe clubbing, and 
cachexia are the consequence of low cardiac output in a 
chronic disease.16 Left ventricular involvement, isolated 
or in combination with biventricular disease, is most 
often encountered in the chronic form of the disease, 
followed by isolated right-side involvement. In the 
latter, the physical examination shows signs of systemic 
venous hypertension with multi-visceral congestion, 
accompanied (or not) by pulmonary hypertension due 
to pulmonary thromboembolism. Some characteristic 
signs include central cyanosis, exophthalmos, giant 
ascites without pedal edema (sometimes accompanied 
by peritoneal fibrosis), hyperpigmentation of the lips 
and gums, proptosis, and parotid swelling. Although 
chest x-ray and electrocardiogram may show several 
abnormalities, none of them are specific. However, the 
echocardiogram is the gold standard technique for the 
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diagnosis of the chronic disease.17 Dense endocardial 
echograms along the mural and valvular endocardium, 
valvular dysfunction, a restrictive filling pattern with 
shrinkage of the cavity, the presence of thrombus, 
and the detection of pericardial effusion are the 
most typical echocardiographic findings.18 MRI adds 
precision to the diagnosis, showing hypoperfused 
fibrotic areas, and confirms the presence of thrombus 
and calcifications.19
The most prominent pathological characteristics 
of EMF20 is a massive deposition of granulation 
tissue and extracellular proteins, mainly collagen 
type I, but also collagen type III and elastic fibers, 
at the endocardium of any or both ventricles. 
This connective tissue surrounds the papillary muscles 
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and covers the walls of the cavities, thickening 
the walls and causing a stiffness that impairs the 
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Typically, the boundaries between the thickened 
endocardium and the myocardium are not clear-cut, 
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cavities (as well as their inlets) are more commonly 
committed, and the outlets are almost always free. In 
spite of the relationship with eosinophilia, significant 
infiltrates by eosinophils are not seen in the majority 
of cases.
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